Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A.   Garipoli V.   Pastore G.   Pagani L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

By Miller E.   Rush M.   Hill A.   Morgan-Capner P.   Forsey T.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months

By Bottiger M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1759-1762

Elsevier

Access to resources Recommend Favorite

MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland

By Johnson H.   Hillary I.B.   McQuoid G.   Gilmer B.A.  

Vaccine, Vol. 13, Iss. 6, 1995-04 ,pp. : 533-537

Elsevier

Access to resources Recommend Favorite

Characterization of measles viruses isolated after measles vaccination

By Kobune F.   Funatu M.   Takahashi H.   Fukushima M.   Kawamoto A.   Iizuka S.   Sakata H.   Yamazaki S.   Arita M.   Wenbo X.   Li-Bi Z.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 370-372

Elsevier

Access to resources Recommend Favorite